Clinical Trials Directory

Trials / Terminated

TerminatedNCT01337635

Vitamin D Deficiency and Atopic Dermatitis

Treatment Of Vitamin D Deficiency And Effect On Atopic Dermatitis Severity

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
7 (actual)
Sponsor
Medical College of Wisconsin · Academic / Other
Sex
All
Age
1 Year – 18 Years
Healthy volunteers
Not accepted

Summary

Atopic dermatitis is a chronic skin disease characterized by a defective skin barrier, inflammation, and increased propensity for skin infections. Vitamin D is a fat-soluble vitamin that is primarily acquired through local production in the skin after ultraviolet light exposure but can also be obtained through natural and supplemental dietary sources. This randomized controlled trial will examine the effects of vitamin D repletion on atopic dermatitis severity in patients with diagnosed deficiency. The investigators hypothesize that pediatric patients with moderate or severe atopic dermatitis and vitamin D deficiency will have improved cutaneous disease after treatment with high dose as compared to standard dose vitamin D.

Conditions

Interventions

TypeNameDescription
DRUGVitamin DErgocalciferol 300,000 IU single oral dose Cholecalciferol 400 IU orally every day for 6 weeks

Timeline

Start date
2010-11-01
Primary completion
2012-12-01
Completion
2013-04-01
First posted
2011-04-19
Last updated
2018-12-05
Results posted
2015-04-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01337635. Inclusion in this directory is not an endorsement.